Delving into the Latest Updates on The Fourth Hospital of Hebei Medical University with Synapse

Overview

Tags

Infectious Diseases

Polyclonal antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Polyclonal antibody	1

Top 5 Target	Count

CD4(T-cell surface antigen CD4)	1

Sedatives are the mostly common prescription for patients with mechanical ventilation due to the disease or therapies.
Ciprofol is a new intravenous anesthetic agent transformed from propofol, and has a similar sedative effect of propofol in previous study.
Whether ciprofol is safe and effective similar with propofol for sedation in ICU patients with mechanical ventilation? Therefor, a multi-center, double-blind, randomized control trial was conducted with a noninferiority design, to compared the rate of successful sedation without hypotension of sedation by ciprofol or propofol in ICU patients with mechanical ventilation.
A Multi-Center, Double-Blind, Randomized Controlled Trial will be launched to evaluate the efficacy and safety of ciprofol versus propofol for sedation in ICU patients with mechanical ventilation.

Start Date01 Aug 2024

Sponsor / Collaborator

Southeast University Affiliated Zhonda Hospital

[+18]

100 Clinical Results associated with The Fourth Hospital of Hebei Medical University

Login to view more data

0 Patents (Medical) associated with The Fourth Hospital of Hebei Medical University

Login to view more data

3,167

Literatures (Medical) associated with The Fourth Hospital of Hebei Medical University

01 Jan 2025·Brain Research

The role of trimethylation on histone H3 lysine 27 (H3K27me3) in temozolomide resistance of glioma

Article

Author: Li, Li ; Li, Yitong ; Guo, Xiaoqiang ; Sui, Aixia ; Dong, Changzheng ; Zhang, Xiaopei ; Shi, Jian

Temozolomide (TMZ) is the first-line chemotherapeutic agent for malignant glioma, but its resistance limited the benefits of the treated patients. In this study, the role and significance of trimethylation of histone H3 lysine 27 (H3K27me3) in TMZ resistance were investigated. Data from twenty advanced glioma patients were collected, and their pathological samples were analyzed for H3K27me3 levels. TMZ sensitivity was compared between glioma cells U87 and TMZ-resistant cells U87TR, with H3K27me3 levels determined in both cells. The effects of H3K27me3 demethylases inhibitor GSK-J4, combined with TMZ, were assessed on the proliferation and migration of U87TR cells. The results indicated that a high level of H3K27me3 predicts longer disease free survival (DFS) and overall survival (OS) in glioma patients receiving TMZ treatment. The H3K27me3 level was lower in U87TR cells compared to U87 cells. GSK-J4 increased the H3K27me3 level in U87TR cells and decreased their resistance to TMZ. In summary, this study identified a novel marker of TMZ resistance in glioma and provided a new strategy to address this challenge. These findings are significant for improving the clinical treatment of glioma in the future.

31 Dec 2024·Renal Failure

Relationship between effective blood flow rate and clinical outcomes in maintenance hemodialysis patients: a single-center study

Author: Zhang, Shenglei ; Wang, Mei ; Li, Jiarui ; Xu, Jinsheng ; Zhang, Zhoucang ; Ding, Jiaxiang

The association between blood flow rate (BFR) and clin. outcomes in patients undergoing maintenance hemodialysis (MHD) is inconclusive.This retrospective study included 175 patients undergoing MHD treatment between July 2015 and March 2022, divided into two groups based on time-averaged effective blood flow rate (eBFR) median value.We investigated arteriovenous fistula (AVF) outcomes and the association of eBFR with all-cause mortality and new major adverse cardiovascular events (MACE).Mean ± SD and median time-averaged eBFR values were 276 ± 24 and 275 mL/min, resp.After adjusting for relevant factors including age, sex, vintage, diabetes, CVD, receiving hemodiafiltration (HDF) treatment and spKt/V, Cox models indicated a low time-averaged eBFR (≤ 275 mL/min) was associated with increased risks of all-cause mortality (hazard ratio [HR] 14.18; 95% confidence interval [CI], 3.14-64.1) and new MACE (HR 3.76; 95% CI, 1.91-7.40) in MHD patients.Continuous Cox models demonstrated each 20 mL/min increase in eBFR linked to a 63% decrease in the risk of all-cause mortality (HR: 0.37, 95% CI: 0.23-0.59) and a 38% decrease in the occurrence of new MACE (HR: 0.62, 95% CI: 0.46-0.84).There was no significant difference in AVF outcomes between the two groups.Our study noted higher eBFR (>275 mL/min) is associated with lower risks of both all-cause mortality and new MACE compared with low eBFR (≤275 mL/min).Increased eBFR is not associated with a higher risk of AVF failure.

31 Dec 2024·Cancer Biology & Therapy

KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis

Article

Author: Han, Jiaxu ; Niu, Wenbo ; Zhang, Juan ; Li, Zhihan ; Meng, Qingyu ; Tian, Zhongtao

In this study, we aimed to investigate the molecular mechanism of Krüppel-like factor 7 (KLF7) in colorectal cancer (CRC) cell invasion and migration. The expression pattern of KLF7 in CRC tissues and the correlation between KLF7 expression and clinical symptoms of CRC were analyzed. CRC cell lines were transfected with si-KLF7, followed by qRT-PCR or western blot detection of KLF7, miR-139-5p, and tumor protein D52 (TPD52) expression, cell counting kit-8 (CCK-8) assay to detect cell viability, and transwell detection of invasion and migration. Chromatin immunoprecipitation (ChIP) analyzed the enrichment KLF7 in the miR-139-5p promoter. The dual-luciferase reporter assay verified the binding relationship between KLF7 and miR-139-5p, and between miR-139-5p and TPD52. In the subcutaneous tumorigenesis experiment, tumor growth was observed and ki67-positive expression was detected. KLF7 is abundantly expressed in CRC cells KLF7 silencing inhibits CRC cell viability, invasion, and migration. KLF7 represses miR-139-5p expression by binding to the miR-139-5p promoter. miR-139-5p targets TPD52 expression. miR-13-5p inhibition or TPD52 overexpression partially counteracted the effect of KLF7 silencing in CRC cells. KLF7 silencing suppresses tumor growth in vivo. In conclusion, KLF7 suppresses miR-139-5p expression by binding to the miR-139-5p promoter, thereby upregulating TPD52 expression and enhancing CRC cell invasion and migration.

100 Deals associated with The Fourth Hospital of Hebei Medical University

Login to view more data

100 Translational Medicine associated with The Fourth Hospital of Hebei Medical University

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

Login to view more data